Nichi-Iko Pharmaceutical Co., Ltd. provided earnings guidance for the fiscal year ending March 31, 2021. For the year, the company expects revenue of JPY 199,000 million. Operating profit of JPY 7,500 million. Profit attributable to owners of parent of JPY 5,200 million.